Abstract Aims To examine the association of a remote monitoring programme (RMP) with all‐cause mortality and hospital admissions for heart failure (HF) within the French healthcare system. Methods and results A national‐scale, real‐world, propensity‐weighted cohort study was conducted using the SNDS French database from August 2018 to December 2022 (NCT06312501). Patients receiving standard of care (SoC) were compared with those receiving RMP (Satelia® Cardio, NP Medical). The Satelia® Cardio algorithm adjusted the monitoring frequency based on symptom and weight changes, and provided tailored web‐based patient education. The RMP included a digital interface for proficient patients and phone monitoring by nurses for those uncomfortable with digital technology. Data were sourced from over 300 healthcare centres across France. A propensity‐weighted Cox regression model was used, supplemented by sensitivity analyses across subgroups. In total, 5357 RMP patients and 13 525 SoC patients were included after weighting. Weighted/adjusted analyses showed lower all‐cause mortality for RMP patients (hazard ratio [HR] 0.64; 95% confidence interval [CI] 0.59–0.70; p < 0.0001), persisting across hospitalization and/or long‐term illness status subgroups (HR 0.52 to 0.75). RMP was neutrally associated with HF hospitalization rates (rate ratio [RR] 0.95; 95% CI 0.89–1.02) but linked to less time in hospital (−2.1%, p < 0.0001) and fewer emergency visits (RR 0.83; 95% CI 0.75–0.92; p = 0.001). Conclusion In France, RMP with customized monitoring frequencies and educational strategies was associated with lower all‐cause mortality, emergency visits, and time spent in hospital in patients with HF which may enhance nationwide HF management.